Showing results (1351-1360 of 1,395) with videos related to

Sort By:
Pageof 140
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Association of Modified Body Mass Index With In-Hospital Outcomes After Intermediate or High-Risk Pulmonary EmbolismDanial Saleem, Mahesh V Madhavan, Caroline Der Nigoghossian, et al.
Medrxiv : the Preprint Server for Health Sciences|February 17, 2021
Emergence in late 2020 of multiple lineages of SARS-CoV-2 Spike protein variants affecting amino acid position 677Emma B Hodcroft, Daryl B Domman, Daniel J Snyder, et al.
The Journal of Clinical Investigation|October 8, 2019
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatmentDaniel M Ramos, Constantin d'Ydewalle, Vijayalakshmi Gabbeta, et al.
Journal of the American Society of Nephrology : JASN|October 15, 2011
APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathyNatalia Papeta, Krzysztof Kiryluk, Ami Patel, et al.
American Heart Journal|December 6, 2021
Effects of long-term testosterone treatment on cardiovascular outcomes in men with hypogonadism: Rationale and design of the TRAVERSE studyShalender Bhasin, A Michael Lincoff, Shehzad Basaria, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 22, 2020
Retinal imaging in Alzheimer's and neurodegenerative diseasesPeter J Snyder, Jessica Alber, Clemens Alt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 29, 2018
A Rationally Designed Fully Human EGFRvIII:CD3-Targeted Bispecific Antibody Redirects Human T Cells to Treat Patient-derived Intracerebral Malignant GliomaPatrick C Gedeon, Teilo H Schaller, Satish K Chitneni, et al.
The Journal of Clinical Endocrinology and Metabolism|September 11, 2019
Prostate-Specific Antigen Levels During Testosterone Treatment of Hypogonadal Older Men: Data from a Controlled TrialGlenn R Cunningham, Susan S Ellenberg, Shalender Bhasin, et al.
Brain : a Journal of Neurology|August 14, 2016
BDNF Val66Met moderates memory impairment, hippocampal function and tau in preclinical autosomal dominant Alzheimer's diseaseYen Ying Lim, Jason Hassenstab, Carlos Cruchaga, et al.
Pageof 140